I-Mab Biopharma
IMAB
#9307
Rank
C$92.77 M
Marketcap
$1.12
Share price
-5.65%
Change (1 day)
-54.39%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): C$4.34 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is C$4.52 Million. a decrease over the revenue in the year 2023 that were of C$0.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 C$0.12 M-139.76%
2022-C$0.32 Million-110.38%
2021C$2.99 M-94.01%
2020 C$50.07 M5798.4%
2019 C$0.84 M-46.01%
2018 C$1.57 M317.83%
2017C$0.37 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$0.31 M-93.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.98 B 21,690.08%๐Ÿ‡บ๐Ÿ‡ธ USA